{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:33:02Z","timestamp":1793413982580,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Asociaci\u00f3n Espa\u00f1ola contra el C\u00e1ncer"},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,12,14]]},"DOI":"10.1038\/s41416-025-03204-0","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T08:09:45Z","timestamp":1759219785000},"page":"1744-1754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Benchmarking standard-of-care and emerging genomic approaches to enhance diagnosis in pediatric acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2097-4796","authenticated-orcid":false,"given":"Jos\u00e9 Vicente","family":"Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayane","family":"Avetisyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Miralles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"de las Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"D\u00edaz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"L\u00f3pez-Benet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Ca\u00f1izo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Such","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0106-7296","authenticated-orcid":false,"given":"Marta","family":"Llop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"3204_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/asheducation-2018.1.137","volume":"2018","author":"KG Roberts","year":"2018","unstructured":"Roberts KG. Genetics and prognosis of ALL in children vs adults. Hematology. 2018;2018:137\u201345. https:\/\/doi.org\/10.1182\/asheducation-2018.1.137.","journal-title":"Hematology"},{"key":"3204_CR2","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","volume":"54","author":"SW Brady","year":"2022","unstructured":"Brady SW, Roberts KG, Gu Z, Shi L, Pounds S, Pei D, et al. The genomic landscape of pediatric acute lymphoblastic leukemia. Nat Genet. 2022;54:1376\u201389. https:\/\/doi.org\/10.1038\/s41588-022-01159-z.","journal-title":"Nat Genet"},{"key":"3204_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBdO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720\u201348. https:\/\/doi.org\/10.1038\/s41375-022-01620-2.","journal-title":"Leukemia"},{"key":"3204_CR4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka H-M, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200\u201328. https:\/\/doi.org\/10.1182\/blood.2022015850.","journal-title":"Blood"},{"key":"3204_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/bjh.12625","volume":"164","author":"BC Medeiros","year":"2013","unstructured":"Medeiros BC, Othus M, Estey EH, Fang M, Appelbaum FR. Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia. Br J Haematol. 2013;164:245\u201350. https:\/\/doi.org\/10.1111\/bjh.12625.","journal-title":"Br J Haematol"},{"key":"3204_CR6","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41375-019-0378-z","volume":"33","author":"KA Rack","year":"2019","unstructured":"Rack KA, Van Den Berg E, Haferlach C, Beverloo HB, Costa D, Espinet B, et al. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms. Leukemia. 2019;33:1851\u201367. https:\/\/doi.org\/10.1038\/s41375-019-0378-z.","journal-title":"Leukemia"},{"key":"3204_CR7","doi-asserted-by":"publisher","unstructured":"Janic D, Peric J, Karan-Djurasevic T, Kostic T, Marjanovic I, Stanic B, et al. Application of targeted next generation sequencing for the mutational profiling of patients with acute lymphoblastic leukemia. J Med Biochem. 2019. https:\/\/doi.org\/10.2478\/jomb-2019-0017.","DOI":"10.2478\/jomb-2019-0017"},{"key":"3204_CR8","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ajh.27175","volume":"99","author":"B Levy","year":"2024","unstructured":"Levy B, Kanagal-Shamanna R, Sahajpal NS, Neveling K, Rack K, Dewaele B, et al. A framework for the clinical implementation of optical genome mapping in hematologic malignancies. Am J Hematol. 2024;99:642\u201361. https:\/\/doi.org\/10.1002\/ajh.27175.","journal-title":"Am J Hematol"},{"key":"3204_CR9","doi-asserted-by":"publisher","unstructured":"Walter W, Iacobucci I, Meggendorfer M. Diagnosis of acute lymphoblastic leukaemia: an overview of the current genomic classification, diagnostic approaches, and future directions. Histopathology. 2024. https:\/\/doi.org\/10.1111\/his.15338","DOI":"10.1111\/his.15338"},{"key":"3204_CR10","doi-asserted-by":"publisher","unstructured":"ISCN 2020. 2020. https:\/\/doi.org\/10.1159\/isbn.978-3-318-06867-2.","DOI":"10.1159\/isbn.978-3-318-06867-2"},{"key":"3204_CR11","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, Van Der Velden VHJ, Bi W, Grimwade D, Pallisgaard N, et al. Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia \u2013 a Europe Against Cancer Program. Leukemia. 2003;17:2318\u201357. https:\/\/doi.org\/10.1038\/sj.leu.2403135.","journal-title":"Leukemia"},{"key":"3204_CR12","doi-asserted-by":"publisher","unstructured":"Gil JV, Such E, Sargas C, Simarro J, Miralles A, P\u00e9rez G, et al. Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia. Int J Mol Sci. 2023;24:4440. https:\/\/doi.org\/10.3390\/ijms24054440.","DOI":"10.3390\/ijms24054440"},{"key":"3204_CR13","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.3390\/cancers15194731","volume":"15","author":"AJ Thomson","year":"2023","unstructured":"Thomson AJ, Rehn JA, Heatley SL, Eadie LN, Page EC, Schutz C, et al. Reproducible bioinformatics analysis workflows for detecting IGH gene fusions in B-Cell acute lymphoblastic leukaemia patients. Cancers. 2023;15:4731. https:\/\/doi.org\/10.3390\/cancers15194731.","journal-title":"Cancers"},{"key":"3204_CR14","doi-asserted-by":"publisher","unstructured":"Heyer EE, Deveson IW, Wooi D, Selinger CI, Lyons RJ, Hayes VM, et al. Diagnosis of fusion genes using targeted RNA sequencing. Nat Commun. 2019. https:\/\/doi.org\/10.1038\/s41467-019-09374-9.","DOI":"10.1038\/s41467-019-09374-9"},{"key":"3204_CR15","doi-asserted-by":"publisher","unstructured":"Thakral D, Kaur G, Gupta R, Bernard-SlagterA, Savola S, Kumar I, et al. Rapid identification of key copy number alterations in B- and T-Cell acute lymphoblastic leukemia by digital multiplex Ligation-Dependent probe amplification. Front Oncol. 2019. https:\/\/doi.org\/10.3389\/fonc.2019.00871.","DOI":"10.3389\/fonc.2019.00871"},{"key":"3204_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ajh.26487","volume":"97","author":"K Rack","year":"2022","unstructured":"Rack K, De Bie J, Ameye G, Gielen O, Demeyer S, Cools J, et al. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping. Am J Hematol. 2022;97:548\u201361. https:\/\/doi.org\/10.1002\/ajh.26487.","journal-title":"Am J Hematol"},{"key":"3204_CR17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.hoc.2009.07.001","volume":"23","author":"K Mr\u00f3zek","year":"2009","unstructured":"Mr\u00f3zek K, Harper DP, Aplan PD. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23:991\u20131010. https:\/\/doi.org\/10.1016\/j.hoc.2009.07.001.","journal-title":"Hematol Oncol Clin North Am"},{"key":"3204_CR18","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/ajh.27435","volume":"99","author":"S Loghavi","year":"2024","unstructured":"Loghavi S, Wei Q, Ravandi F, Quesada AE, Routbort MJ, Hu S, et al. Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia. Am J Hematol. 2024;99:1959\u201368. https:\/\/doi.org\/10.1002\/ajh.27435.","journal-title":"Am J Hematol"},{"key":"3204_CR19","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1182\/bloodadvances.2022007583","volume":"7","author":"B Levy","year":"2022","unstructured":"Levy B, Baughn LB, Akkari Y, Chartrand S, LaBarge B, Claxton D, et al. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation. Blood Adv. 2022;7:1297\u2013307. https:\/\/doi.org\/10.1182\/bloodadvances.2022007583.","journal-title":"Blood Adv"},{"key":"3204_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41375-021-01448-2","volume":"36","author":"AV Moorman","year":"2021","unstructured":"Moorman AV, Barretta E, Butler ER, Ward EJ, Twentyman K, Kirkwood AA, et al. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. Leukemia. 2021;36:625\u201336. https:\/\/doi.org\/10.1038\/s41375-021-01448-2.","journal-title":"Leukemia"},{"key":"3204_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41416-023-02309-8","volume":"129","author":"G Bedics","year":"2023","unstructured":"Bedics G, Egyed B, Kotmayer L, Bernard-Slagter A, de Groot K, Beko A, et al. PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia. Br J Cancer. 2023;129:455\u201365. https:\/\/doi.org\/10.1038\/s41416-023-02309-8.","journal-title":"Br J Cancer"},{"key":"3204_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/genes14030686","volume":"14","author":"LM Vieler","year":"2023","unstructured":"Vieler LM, Nilius-Eliliwi V, Schroers R, Vangala DB, Nguyen HP, Gerding WM. Optical genome mapping reveals and characterizes recurrent aberrations and new fusion genes in adult ALL. Genes. 2023;14:686 https:\/\/doi.org\/10.3390\/genes14030686.","journal-title":"Genes"},{"key":"3204_CR23","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.3390\/cancers12102815","volume":"12","author":"JA Rehn","year":"2020","unstructured":"Rehn JA, O\u2019Connor MJ, White DL, Yeung DT. DUX hunting\u2014clinical features and diagnostic challenges associated with DUX4-rearranged leukaemia. Cancers. 2020;12:2815 https:\/\/doi.org\/10.3390\/cancers12102815.","journal-title":"Cancers"},{"key":"3204_CR24","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1200\/jco.2017.74.3617","volume":"36","author":"M Stanulla","year":"2018","unstructured":"Stanulla M, Dagdan E, Zaliova M, Moricke A, Palmi C, Cazzaniga G, et al. IKZF1Plus defines a new minimal residual disease\u2013dependent very-poor prognostic profile in pediatric B-Cell precursor acute lymphoblastic leukemia. J Clin Oncol. 2018;36:1240\u20139. https:\/\/doi.org\/10.1200\/jco.2017.74.3617.","journal-title":"J Clin Oncol"},{"key":"3204_CR25","doi-asserted-by":"publisher","first-page":"e892","DOI":"10.1097\/hs9.0000000000000892","volume":"7","author":"C Palmi","year":"2023","unstructured":"Palmi C, Bresolin S, Junk S, Fazio G, Silvestri D, Zaliova M, et al. Definition and Prognostic value of PH-like and IKZF1Plus status in children with down syndrome and B-cell precursor acute lymphoblastic leukemia. HemaSphere. 2023;7:e892 https:\/\/doi.org\/10.1097\/hs9.0000000000000892.","journal-title":"HemaSphere"},{"key":"3204_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/mph.0000000000002456","volume":"44","author":"P Naji","year":"2022","unstructured":"Naji P, Khatami M, Heidari MM, Hashemi A, Jenabzadeh A, Chamani R, et al. Mutational analysis of the VPREB1 gene of Pre-BCR complex in a cohort of sporadic pediatric patients with B-Cell acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2022;44:210\u20139. https:\/\/doi.org\/10.1097\/mph.0000000000002456.","journal-title":"J Pediatr Hematol Oncol"},{"key":"3204_CR27","doi-asserted-by":"publisher","first-page":"e0162638","DOI":"10.1371\/journal.pone.0162638","volume":"11","author":"D Chen","year":"2016","unstructured":"Chen D, Zheng J, Gerasimcik N, Lagerstedt K, Sjorgen H, Abrahamsson J, et al. The expression pattern of the pre-B cell receptor components correlates with cellular stage and clinical outcome in acute lymphoblastic leukemia. PLoS ONE. 2016;11:e0162638 https:\/\/doi.org\/10.1371\/journal.pone.0162638.","journal-title":"PLoS ONE"},{"key":"3204_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/jpm10040244","volume":"10","author":"N Vega-Garcia","year":"2020","unstructured":"Vega-Garcia N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garc\u00e9s C, et al. Helpful criteria when implementing NGS panels in childhood lymphoblastic leukemia. J Pers Med. 2020;10:244 https:\/\/doi.org\/10.3390\/jpm10040244.","journal-title":"J Pers Med"},{"key":"3204_CR29","doi-asserted-by":"publisher","unstructured":"Llop M, Sargas C, Barrag\u00e1n E. The role of next-generation sequencing in acute myeloid leukemia. Curr Opin Oncol. 2022. https:\/\/doi.org\/10.1097\/cco.0000000000000899.","DOI":"10.1097\/cco.0000000000000899"},{"key":"3204_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41588-023-01640-3","volume":"56","author":"M Umeda","year":"2024","unstructured":"Umeda M, Ma J, Westover T, Ni Y, Song G, Maciaszek JL, et al. A new genomic framework to categorize pediatric acute myeloid leukemia. Nat Genet. 2024;56:281\u201393. https:\/\/doi.org\/10.1038\/s41588-023-01640-3.","journal-title":"Nat Genet"},{"key":"3204_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","volume":"51","author":"Z Gu","year":"2019","unstructured":"Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019;51:296\u2013307. https:\/\/doi.org\/10.1038\/s41588-018-0315-5.","journal-title":"Nat Genet"},{"key":"3204_CR32","doi-asserted-by":"publisher","first-page":"e1003997","DOI":"10.1371\/journal.pgen.1003997","volume":"9","author":"ZK Atak","year":"2013","unstructured":"Atak ZK, Gianfelici V, Hulselmans G, De Keersmaecker K, Devasia AG, Geerdens E, et al. Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-Cell acute lymphoblastic leukemia. PLoS Genet. 2013;9:e1003997 https:\/\/doi.org\/10.1371\/journal.pgen.1003997.","journal-title":"PLoS Genet"},{"key":"3204_CR33","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283706","author":"Z Hu","year":"2023","unstructured":"Hu Z, Jia Z, Liu J, Mao A, Han H, Gu Z. MD-ALL: an integrative platform for molecular diagnosis of B-acute lymphoblastic leukemia. Haematologica. 2023. https:\/\/doi.org\/10.3324\/haematol.2023.283706. Published online November 16.","journal-title":"Haematologica"},{"key":"3204_CR34","doi-asserted-by":"publisher","first-page":"e939","DOI":"10.1097\/hs9.0000000000000939","volume":"7","author":"T Beder","year":"2023","unstructured":"Beder T, Hansen B-T, Hartmann AM, Zimmermann J, Amelunxen E, Wolgast N, et al. The gene expression classifier ALLCatchR identifies B-cell precursor ALL subtypes and underlying developmental trajectories across age. HemaSphere. 2023;7:e939 https:\/\/doi.org\/10.1097\/hs9.0000000000000939.","journal-title":"HemaSphere"},{"key":"3204_CR35","doi-asserted-by":"publisher","first-page":"7402","DOI":"10.1182\/bloodadvances.2023010385","volume":"7","author":"A Gu","year":"2023","unstructured":"Gu A, Schmidt B, Lonsdale A, Jalaldeen R, Kosasih HJ, Brown LM, et al. TALLSorts: a T-cell acute lymphoblastic leukemia subtype classifier using RNA-seq expression data. Blood Adv. 2023;7:7402\u20136. https:\/\/doi.org\/10.1182\/bloodadvances.2023010385.","journal-title":"Blood Adv"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03204-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03204-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03204-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:04:34Z","timestamp":1764180274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03204-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,12,14]]}},"alternative-id":["3204"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03204-0","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the institutional ethics committee of Instituto de Investigaci\u00f3n Sanitaria La Fe for studies involving humans on December 22, 2021 (2021-045-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from parents or legal guardians of all patients according to the recommendations of the Human Rights Declaration and the Helsinki Conference.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}